Abstract：
OBJECTIVE: To analyse the litigation trends and the reasons for claims within the specialty of Urology, within the UK National Health Service (NHS), over a 16-year period.
METHODS: Data were requested from NHS Resolution under the Freedom of Information Act 2000. This included the total number of claims in Urology, the number of these that were successful (settled or closed), and the costs in damages paid out per financial year between 2006 and 2022. A breakdown of the successful claims by their primary cause was also collected. These were coded into the categories: \'non-operative\', \'intraoperative\', \'postoperative\', and \'other\'.
RESULTS: A total of 4124 litigation claims were made between 2006 and 2022 and 60.9% (2511/4124) of these claims were successful. In all, £145 million (British pounds) was paid out in damages. The number of successful claims increased 2.9-fold from the start to end of this 16-year period, and the costs in damages paid out increased 10-fold. Regarding primary causes for the successful claims, failure or delay in treatment (20.9%, 525/2511), failure or delay in diagnosis (14.5%, 364/2511), and intraoperative problems (9.1%, 229/2511) accounted for the highest proportion. Overall, non-operative causes for successful claims accounted for 73.3% (1840/2511), intraoperative for 20.1% (504/2511), and postoperative for 3.9% (98/2511).
CONCLUSIONS: The number of successful urological litigation claims, and their associated costs is rising. The majority are due to non-operative causes, which may be partially explained by NHS waiting lists alongside the effects of the coronavirus disease 2019 (COVID-19) pandemic.
METHODS: Data were requested from NHS Resolution under the Freedom of Information Act 2000. This included the total number of claims in Urology, the number of these that were successful (settled or closed), and the costs in damages paid out per financial year between 2006 and 2022. A breakdown of the successful claims by their primary cause was also collected. These were coded into the categories: \'non-operative\', \'intraoperative\', \'postoperative\', and \'other\'.
RESULTS: A total of 4124 litigation claims were made between 2006 and 2022 and 60.9% (2511/4124) of these claims were successful. In all, £145 million (British pounds) was paid out in damages. The number of successful claims increased 2.9-fold from the start to end of this 16-year period, and the costs in damages paid out increased 10-fold. Regarding primary causes for the successful claims, failure or delay in treatment (20.9%, 525/2511), failure or delay in diagnosis (14.5%, 364/2511), and intraoperative problems (9.1%, 229/2511) accounted for the highest proportion. Overall, non-operative causes for successful claims accounted for 73.3% (1840/2511), intraoperative for 20.1% (504/2511), and postoperative for 3.9% (98/2511).
CONCLUSIONS: The number of successful urological litigation claims, and their associated costs is rising. The majority are due to non-operative causes, which may be partially explained by NHS waiting lists alongside the effects of the coronavirus disease 2019 (COVID-19) pandemic.
摘要：
目的：分析泌尿外科专业的诉讼趋势和索赔原因，在英国国家卫生服务（NHS）内，超过16年。
方法：根据2000年《信息自由法》，从NHS决议中要求提供数据。这包括泌尿外科的索赔总数，成功(结算或关闭)的数量，以及2006年至2022年每个财政年度支付的损害赔偿费用。还收集了按主要原因分列的成功索赔。这些被编码为以下类别:\“非手术\”，\'术中\',\'术后\',和\'其他\'。
结果：在2006年至2022年期间，共提出了4124项诉讼索赔，其中60.9％（2511/4124）的诉讼成功。总之,支付了1.45亿英镑（英镑）的赔偿金。从这16年的开始到结束，成功的索赔数量增加了2.9倍，支付的损害赔偿成本增加了10倍。关于成功索赔的主要原因，治疗失败或延误(20.9%，525/2511），诊断失败或延迟(14.5%，364/2511)，术中问题(9.1%，229/2511)所占比例最高。总的来说,成功索赔的非手术原因占73.3%(1840/2511)，术中20.1%(504/2511)，术后为3.9%(98/2511)。
结论：成功的泌尿外科诉讼索赔的数量，他们的相关成本正在上升。大多数是由于非手术原因，这可能部分解释为NHS等待名单以及2019年冠状病毒病(COVID-19)大流行的影响。
方法：根据2000年《信息自由法》，从NHS决议中要求提供数据。这包括泌尿外科的索赔总数，成功(结算或关闭)的数量，以及2006年至2022年每个财政年度支付的损害赔偿费用。还收集了按主要原因分列的成功索赔。这些被编码为以下类别:\“非手术\”，\'术中\',\'术后\',和\'其他\'。
结果：在2006年至2022年期间，共提出了4124项诉讼索赔，其中60.9％（2511/4124）的诉讼成功。总之,支付了1.45亿英镑（英镑）的赔偿金。从这16年的开始到结束，成功的索赔数量增加了2.9倍，支付的损害赔偿成本增加了10倍。关于成功索赔的主要原因，治疗失败或延误(20.9%，525/2511），诊断失败或延迟(14.5%，364/2511)，术中问题(9.1%，229/2511)所占比例最高。总的来说,成功索赔的非手术原因占73.3%(1840/2511)，术中20.1%(504/2511)，术后为3.9%(98/2511)。
结论：成功的泌尿外科诉讼索赔的数量，他们的相关成本正在上升。大多数是由于非手术原因，这可能部分解释为NHS等待名单以及2019年冠状病毒病(COVID-19)大流行的影响。
